You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2026

Profile for India Patent: 6567DEN2014


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for India Patent: 6567DEN2014

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 28, 2026 Bristol Myers Squibb SPRYCEL dasatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent IN6567DEN2014: Scope, Claims, and Patent Landscape

Last updated: August 9, 2025

Introduction

Patent IN6567DEN2014, granted in India, pertains to a novel pharmaceutical invention. For stakeholders in the biopharmaceutical sector, understanding its scope, claims, and the overall patent landscape is crucial for strategic decision-making, including research direction, IP management, and competitive analysis. This analysis dissects the patent’s claims, evaluates its broadness and enforceability, and explores the landscape context within which it exists.


Background and Patent Overview

Patent IN6567DEN2014 was granted by the Indian Patent Office in 2014, focusing on a specific drug or formulation innovation. The patent claims extend to medicinal compounds, compositions, or methods of use, aligning with typical pharmaceutical patent standards. Its filing date, priority, and claim priority rights are essential for establishing its position within the patent timeline.


Scope and Claims Analysis

Claims Structure

The claims form the core of the patent's scope. In India, pharmaceutical patents must clearly define the invention's technical features. Patent IN6567DEN2014 predominantly features:

  • Independent claims: Define the core invention, including the drug's chemical composition, process, or formulation.
  • Dependent claims: Elaborate on specific embodiments, formulations, or use cases, narrowing the scope for particular applications.

Scope of the Patent Claims

The scope typically includes:

  • Chemical Composition: Patent claims likely encompass a specific active pharmaceutical ingredient (API) or a novel combination of APIs, characterized by unique chemical structures or modifications.

  • Pharmaceutical Formulation: Claims may extend to specific formulations—e.g., sustained-release or bioavailability-enhanced versions—assuming novelty and inventive step.

  • Method of Treatment: If claimed, the patent covers specific methods of using the drug for treating particular conditions, leveraging the compound's therapeutic efficacy.

The breadth of these claims depends on how comprehensively the patent draft details the invention. Broad claims offer wider protection but face higher scrutiny during patent prosecution and potential challenges.

Claim Validity and Robustness

  • Novelty and Inventive Step: The claims must be supported by a detailed description demonstrating inventive progress over prior art, such as existing formulations or known compounds [1].

  • Support and Clarity: The claims are sufficiently supported if the patent document provides detailed experimental data, including pharmacological studies, chemical synthesis routes, and stability data.

  • Potential Limitations: India's patent law restricts patenting only for inventions that are novel, involve an inventive step, and are capable of industrial application. Claims overly broad or inadequately supported risk invalidation.


Patent Landscape Context

Prior Art and Related Patents

Examining the patent landscape reveals whether IN6567DEN2014 is a pioneering patent or part of a crowded field. Similar patents from:

  • Other Indian patents: Patent searches in databases like Indian Patent Office (IPO) reveal existing compositions or methods [2].

  • International patents: WIPO and USPTO records can indicate global innovations related to the same API or therapeutic class, influencing the scope of the Indian patent.

Legal and Patentability Challenges

In India, patents can face opposition based on:

  • Lack of novelty: Prior disclosures or publications.

  • Obviousness: If the invention is an incremental modification over prior art.

  • Public health considerations: The patent might be challenged if it is perceived to restrict access to essential medicines.

Patent Term and Enforcement

The patent's enforceability depends on its filing date (2014) and term (20 years from the filing date), suggesting protection until 2034, barring extensions or legal disputes. Enforcement strategies include patent litigation, opposition proceedings, and licensing negotiations.


Strategic Implications

  • Research and Development: Companies can analyze whether the patent’s scope overlaps with existing inventions to avoid infringement and identify areas for innovation.

  • Patent Licensing and Commercialization: The patent owner can leverage the patent for licensing agreements or negotiations with generic manufacturers, especially considering Indian patent law’s emphasis on healthcare access.

  • Opposition and Challenges: Competitors may challenge the patent within the compulsory period following grant, particularly if they find prior art or procedural flaws.


Conclusion

Patent IN6567DEN2014 delineates a defined scope centered on a specific pharmaceutical composition or method. Its claims, if adequately supported, provide strong protection within India's IP landscape, influencing competition, R&D investments, and access policies. The broader landscape underscores the importance of continuous monitoring for potential challenges or adjacent patents to safeguard or navigate the rights effectively.


Key Takeaways

  • Assessment of Scope: The patent’s scope hinges on the specificity and breadth of its claims; detailed claims covering both composition and use typically afford stronger protection.

  • Landscape Positioning: A thorough prior art search is essential to confirm novelty and patentability, avoiding infringement and enhancing strategic positioning.

  • Legal Considerations: Vigilance regarding opposition proceedings and potential challenges is critical, especially given India’s emphasis on public health and patentability standards.

  • Strategic Limitations: Broad claims may be vulnerable; narrow, well-supported claims tend to withstand legal scrutiny.

  • Market Leverage: The patent’s remaining life provides opportunities for licensing, collaborations, or R&D pivots in the rapidly evolving pharmaceutical arena.


FAQs

  1. What is the core inventive element of patent IN6567DEN2014?
    It concerns a specific pharmaceutical composition or method likely involving a novel API or formulation, as disclosed in the patent document's claims.

  2. How broad are the patent’s claims?
    The breadth depends on the language used—if claims cover a class of compounds or formulations without specific limitations, protection is broader; conversely, specific claims limit scope but improve robustness.

  3. Can this patent be challenged in India?
    Yes, via opposition proceedings or post-grant challenges, particularly if prior art or procedural issues are identified that invalidate its claims.

  4. What is the patent landscape’s impact on future innovation?
    The patent landscape indicates the level of innovation activity; overlapping patents can signify crowded fields, prompting innovators to carve out new niches.

  5. When does the patent IN6567DEN2014 expire?
    Assuming standard 20-year term from the filing date (2014), it will expire around 2034 unless extended or challenged.


References

[1] Indian Patent Rules and Guidelines – Patentability requirements.
[2] Indian Patent Office Patent Search Database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.